Skip to main content
Log in

Unfractionated Heparin Activity Testing in Preparations and Substances

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The development of efficient production of unfractionated heparin (UFH) preparations, which are widely used in clinical practice, is currently a critical problem. According to WHO guidelines, specific and selective methods for monitoring heparin activity in preparations and substances must be used in the quality assurance system for producing pharmaceutical preparations. A clotting method for measuring UFH activity in its preparations and substances according to the coagulation method recommended by the State Pharmacopoeia of the Russian Federation was developed based on the created test system. The method was evaluated using the main analytical characteristics. The results obtained from the developed test were shown to be comparable with those from UFH activity determinations using the chromogenic method recommended by the State and European pharmacopoeias. The established accuracy, sensitivity, and precision allowed the validated coagulation method and the created test system to be recommended for inclusion in UFH process monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. D. M. Zubairov, Molecular Bases of Blood Clotting and Thrombus Formation [in Russian], FEN, Kazan (2000), pp. 219 – 240.

  2. R. U. Kolmen, Disruption of Thrombin-formation Reactions [in Russian], Meditsina, Moscow (1988), pp. 175 – 207.

  3. M. Johnston, in: Quality in Laboratory Hemostasis and Thrombosis, S. Kitchen, J. D. Olson, and F. E. Preston (eds.), Wiley-Blackwell (2009), pp. 170 – 178.

  4. J. Choay, M. Petitou, J. C. Lormeau, et al., Biochem. Biophys. Res. Commun., 116, 492 – 499 (1983).

    Article  CAS  Google Scholar 

  5. S. D. Niles, R. G. Sutton, J. Ploessl, et al., J. Extracorpor. Technol., 7, 197 – 200 (1995).

  6. A. G. Turpie, A. S. Gallus, and J. A. Hoek, N. Engl. J. Med., 344, 619 – 625 (2001).

    Article  CAS  Google Scholar 

  7. European Pharmacopoeia 8.0. 2.7.5, Assay of Heparin, 01 /2008:20705 (2013), pp. 237 – 238.

  8. WHO Expert Committee on Specification for Pharmaceutical Preparations, Thirty-second report, WHO, Geneva (1992), pp. 117 – 121.

  9. State Pharmacopoeia of the RF, XIIIth Ed., Quantitative Determination of Heparin. Clotting Method [in Russian], GPM 1.8.2.0003 (2015), pp. 921 – 922.

  10. European Pharmacopoeia, 8.3. 2.7.5, Assay of Heparin, 01 /2015:20705 (2015), p. 4187.

  11. I. Gouin-Thibaut, I. Martin-Toutain, E. Peynaud-Debayle, et al., Thromb. Res., 129, 666 – 667 (2012).

    Article  CAS  Google Scholar 

  12. A. M. van den Besselaar, A. Sturk, and G. L. Reijnierse, Thromb. Res., 107, 235 – 240 (2002).

    Article  Google Scholar 

  13. S. Kitchen, I. Jennings, and T. Woods, J. Clin. Pathol., 49, 10 – 14 (1996).

    Article  CAS  Google Scholar 

  14. K. Cuker, A. Raby, K. A. Moffat, et al., Thromb. Haemostasis, 104, 837 – 844 (2010).

    Article  CAS  Google Scholar 

  15. GOST R 53022.2 – 2008, “Rules for estimating analytical sensitivity of clinical laboratory study methods,” Standartinform, Moscow (2009), p. 6.

  16. V. I. Dvorkin, V. N. Malakhov, E. V. Zaikin, et al., Zh. Anal. Khim., 40, 2117 – 2124 (1985).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. L. Berkovskii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 9, pp. 49 – 51, September, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berkovskii, A.L., Sergeeva, E.V. & Suvorov, A.V. Unfractionated Heparin Activity Testing in Preparations and Substances. Pharm Chem J 52, 796–798 (2018). https://doi.org/10.1007/s11094-018-1902-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1902-6

Keywords

Navigation